. home.aspx



AcelRx Pharmaceuticals ZALVISO Recognized for Innovative Design with Prestigious Red Dot Award

June 08, 2017 / World Pharma Today

Announced that ZALVISO® (sufentanil sublingual tablet system) has been selected for a Red Dot Award in the category of Product Design – Life Sciences and MedicineThe Red Dot Awards in this category are presented to products that display innovative design features that improve or enhance patient experience.